One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: The Chicago Heart Association Detection Project in Industry (CHA) study

Journal of Clinical Epidemiology

Volumn 50, Issue 12, 1997, Pages 1369-1376

  Orencia, Anthony J ^a,b   Daviglus, Martha L ^a   Dyer, Alan R ^a   Walsh, Molly ^a   Greenland, Philip ^a   Stamler, Jeremiah ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary heart disease; Epidemiologic study; Nondiabetic; Plasma glucose; Risks; Stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MALE; MORTALITY; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; STROKE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CEREBROVASCULAR DISORDERS; CHICAGO; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0031467071     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00201-1     Document Type: Article

References (37)

1. Pan W-P, Cedres L, Liu K, Dyer A, Schoenberger J, Shekelle R, Stamler R, Smith D, Collette P, Stamler J Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 123:1986;504-516.
2. Barrett-Connor E, Wingard DL Sex differential in ischemic heart disease mortality in diabetics. A prospective population-based study Am J Epidemiol. 118:1983;489-496.
3. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H Mortality from coronary heart disease and stroke in relation to degree of glycemia. The Whitehall Study Br Med J. 287:1983;867-870.
4. Kannel WB, McGee DL Diabetes and glucose tolerance as risk factors for cardiovascular disease. The Framingham Study Diabetes Care. 2:1979;120-126.
5. Heyden S, Heiss G, Bartel AG, Hames CG Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis. 33:1980;265-273.
6. Butler WJ, Ostrander LD Jr., Carman WJ, Lamphiear DE Mortality from coronary heart disease in the Tecumseh Study. Long-term effect of diabetes mellitus, glucose tolerance, and other risk factors. Am J Epidemiol. 121:1985;541-547.
7. Roehmholdt M, Palumbo P, Whisnant JP, Eleveback L Transient ischemic attack and stroke in a community-based diabetic cohort. Mayo Clin Proc. 58:1983;56-58.
8. Abbott RD, Donahue RP, Macmahon SW, Reed DM, Yano K Diabetes and the risk of stroke. The Honolulu Heart Program J Am Med Assoc. 257:1987;949-952.
9. Bierman EL Atherogenesis in diabetes. Arteriosclerosis and Thrombosis. 12:1992;647-655.
10. Reaven GM Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
11. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L Is borderline fasting hyperglycemia a risk for cardiovascular death? J Chron Dis. 37:1984;773-779.
12. Donohue R, Abbott RD, Reed D, Yano K Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes. 36:1987;689-692.
13. Ohlson LO, Svarsudd K, Welin L, Eriksson H, Wilhelmsen L, Tibblin G, Larsson B Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality. A 17-year follow-up study of men born in 1913 Diabetes Med. 3:1986;33-37.
14. Miller GJ, Kirkwood BR, Beckles GL, Alexis SD, Carson DC, Byam NT Adult male all-cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. Int J Epidemiol. 17:1988;62-69.
15. Pyorala K Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease. Results from two population studies in Finland. Diabetes Care. 2:1979;131-141.
16. Welborn TA, Wearne K Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 2:1979;154-160.
17. Cruz-Vidal M, Garcia-Palmieri M, Costas R, Sorlie PD, Havlik RJ Abnormal blood glucose and coronary heart disease. The Puerto Rico Heart Health Program Diabetes Care. 6:1983;556-561.
18. Stamler R, Stamler J, (Eds). Asymptomatic hyperglycemia and coronary heart disease: A series of papers from the International Collaborative Group based on studies in fifteen populations. J Chronic Dis 1979; 32: 683-837.
19. Feskens E, Kromhout D Glucose tolerance and the risk of cardiovascular diseases. The Zutphen Study J Clin Epidemiol. 11:1992;1327-1334.
20. Stamler R, Stamler J, Lindberg HA, Marquardt J, Berkson DM, Paul O, Lepper M, Dyer A, Stevens E Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chron Dis. 32:1979;805-815.
21. Stamler R, Stamler J, Schoenberger J, Shekelle R, Collette P, Shekelle S, Dyer A, Garside D, Wannamaker J Relationship of glucose tolerance to prevalence of ECG abnormalities and to 5-year mortality from cardiovascular disease. Findings of the Chicago Heart Association Detection Project in Industry J Chron Dis. 32:1979;817-828.
22. Burchfiel CM, Curb D, Rodriguez B, Abbott R, Chiu D, Yano K Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program Stroke. 25:1994;951-957.
23. Haheim L, Holme I, Hjermann I, Leren P Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study Stroke. 26:1995;774-777.
24. Persky V, Dyer A, Stamler J, Shekelle R, Schoenberger J, Wannamaker J, Upton M The relationship between postload plasma glucose and blood pressure at different resting heart rates. J Chron Dis. 32:1979;263-268.
25. Levine W, Dyer A, Shekelle R, Schoenberger J, Stamler J Postload plasma glucose and cancer mortality in middle-aged men and women. Am J Epidemiol. 131:1990;254-262.
26. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity. Findings from long-term follow-up of Chicago cohorts Cardiology. 82:1993;191-222.
27. Hoffman WS A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem. 120:1937;51-55.
28. Department of Health, Education, and Welfare. International Classification of Diseases, Adapted for Use in the United States, 8th Rev. ICDA. Vol. 1. Tabular List. Washington, DC: Government Printing Office; 1967. (DHEW publication no. (PHS) 1693.).
29. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless L, Barnes R, Cram K Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 25:1994;66-73. Hutchinson R, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators.
30. Wilterdink JL, Easton JD Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol. 49:1992;857-863.
31. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
32. Vaccaro O, Ruth KJ, Stamler J Relationship of postload plasma glucose to mortality with 19-yr follow-up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study Diabetes Care. 15:1992;1328-1334.
33. Liu K, Stamler J, Stamler R, Cooper R, Shekelle R, Schoenberger J, Berkson DM, Lindberg H, Marquardt J, Stevens E, Tokich T Methodological problems in characterizing an individual's plasma glucose level. J Chron Dis. 35:1982;475-485.
34. Baron AD, Steinberg H, Chaker H, Leaming R, Johnson A, Brechtel G Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest. 96:1995;786-792.
35. Steinberg H, Brechtel G, Johnson A, Fineberg N, Baron AD Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest. 94:1994;1172-1179.
36. Baron AD Hemodynamic actions of insulin. Am J Physiol. 267:1994;E187-E202.
37. Baron AD Pathogenesis and measurement of insulin resistance in hypertension. Current Opinion in Nephrology and Hypertension. 3:1994;631-635.